Full-Time

Despatch QC Inspector

Updated on 7/21/2026

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

No salary listed

Cardiff, UK

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Google Cloud Platform

Get referred to PCI Pharma Services

Find people who can refer or advise you

Requirements
  • GCSEs in Maths & English
  • NVQ2 in a relevant qualification
  • BTEC National Diploma in pharmaceutical science
  • NVQ/SVQ level 3 in pharmacy services
  • National Certificate in pharmaceutical science
  • Previous experience within a distribution/warehouse environment
  • Previous experience within a GMP environment
  • A high level of attention to detail
  • Experience in the clinical supply field
  • Understanding of Quality Standards including GMP, GCP and GDP
  • Knowledge of Sage 200 or similar enterprise management systems
  • IT literate in standard packages (MS Office)
  • Good written and communication skills
  • Behavioural Competencies: Customer Service
  • Behavioural Competencies: Team player
  • Behavioural Competencies: Judgement and decision making
  • Behavioural Competencies: Resilience
  • Behavioural Competencies: Self Confidence
  • Behavioural Competencies: Excellent written and verbal communication
  • Behavioural Competencies: Self Motivation/ achievement drive
  • Behavioural Competencies: Ability to work without supervision
  • Behavioural Competencies: Trustworthiness
  • Behavioural Competencies: Conscientiousness
Responsibilities
  • Ensuring that all activities are carried to GMP and GDP
  • Performing the post pick verification of Clinical Trial shipments to ensure that the appropriate supplies have been picked and have been prepared ready for despatch correctly
  • Performing the verification that temperature controlled shipments (e.g cold chain, frozen) have been configured correctly including the activation of temperature monitoring devices
  • Inspections of pick and pack cubicles or areas before materials or products are introduced to ensure the absence of materials or products from previous operation
  • Quality oversight of all point of despatch labelling
  • Perform spot checks of warehouse log books to ensure accuracy and compliance with Good Documentation Practice
  • Cross functional support with the QC inspector role
  • Assisting QA with the investigation of customer complaints and deviations
Desired Qualifications
  • Experience within a quality role

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Get referred to PCI Pharma Services

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • San Diego’s 2028 line more than doubles RTU syringe and cartridge capacity.
  • Bedford’s line reaches 33 million annual vial units, strengthening sterile supply.
  • Autoinjector capacity exceeds 250 million units annually after the 2027 line.

What critics are saying

  • San Diego capacity arrives only in first-half 2028, leaving competitors more immediate supply.
  • Large sterile buildouts create execution risk from validation, yield, and regulatory delays.
  • Customer concentration can strand expensive capacity if programs are delayed or cancelled.

What makes PCI Pharma Services unique

  • PCI combines sterile fill-finish, device assembly, packaging, and cold-chain support.
  • San Diego and Bedford add specialized capacity for prefilled syringes, vials, and lyophilization.
  • Phased U.S. and European investments target clinical-through-commercial drug-device programs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.